0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Release of Prostaglandin E 2 from the Hypothalamus Depends on Extracellular Ca 2+ Availability: Relation to LHRH Release

      ,

      Neuroendocrinology

      S. Karger AG

      Prostaglandin E2 , LHRH, Extracellular Ca2+ , Median eminence

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The present experiments were performed to investigate the role of extracellular Ca<sup>2+</sup> in the process of prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) release from the median eminence (ME) of the hypothalamus. Changes in the release of LHRH were also evaluated. Incubation of ME fragments with different concentrations of K<sup>+</sup> induced a dose-related increase in PGE<sub>2</sub> and LHRH release. The effect of K<sup>+</sup> depended upon the Ca<sup>2+</sup> concentration in the incubation medium. A Ca<sup>2+</sup> concentration of 0.1 mM was sufficient to permit a significant response in both PGE<sub>2</sub> and LHRH release to K<sup>+</sup>. The effect of a maximal K<sup>+</sup> concentration (56 mM)was almost completely obliterated by omitting Ca<sup>2+</sup> from the incubation medium and by chelating the remaining Ca<sup>2+</sup> with EDTA or EGTA. The Ca<sup>2+</sup> ionophore A23187, tested at different concentrations (1–50 µ M) significantly increased the release of both PGE<sub>2</sub> and LHRH from the ME in a Ca<sup>2+</sup>-dependent manner. A Ca<sup>2+</sup> concentration of 0.25 mM allowed maximal LHRH response to the ionophore, but permitted only a partial (50%) PGE<sub>2</sub> response. Blockade of Ca<sup>2+</sup> channels with Verapamil, a Ca<sup>2+</sup> entry blocker, prevented the effect of K<sup>+</sup> on both PGE<sub>2</sub> and LHRH release in a dose-dependent manner. The results demonstrate that release of PGE<sub>2</sub> from ME nerve terminals depends upon the concentration of extracellular Ca<sup>2+</sup> and suggest that PGE<sub>2</sub> release is initiated by an increase in Ca<sup>2+</sup> influx to the terminals. In addition, the data provide further evidence that release of LHRH is, to a significant extent, a function of Ca<sup>2+</sup> influx through Ca<sup>2+</sup> voltage-dependent channels.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1984
          1984
          28 March 2008
          : 39
          : 5
          : 442-447
          Affiliations
          Department of Physiology, University of Texas Health Science Center, Dallas, Tex., USA
          Article
          124018 Neuroendocrinology 1984;39:442–447
          10.1159/000124018
          6096751
          © 1984 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 6
          Categories
          Original Paper

          Comments

          Comment on this article